Im Cannabis CORP. 6-K Filing
Ticker: IMCC · Form: 6-K · Filed: Dec 30, 2025 · CIK: 1792030
| Field | Detail |
|---|---|
| Company | Im Cannabis CORP. (IMCC) |
| Form Type | 6-K |
| Filed Date | Dec 30, 2025 |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 6-K filing submitted by Im Cannabis CORP. (ticker: IMCC) to the SEC on Dec 30, 2025.
How long is this filing?
Im Cannabis CORP.'s 6-K filing is 1 pages with approximately 275 words. Estimated reading time is 1 minutes.
Where can I view the full 6-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 275 words · 1 min read · ~1 pages · Grade level 10.5 · Accepted 2025-12-30 07:52:02
Filing Documents
- zk2534143.htm (6-K) — 9KB
- exhibit_99-1.htm (EX-99.1) — 9KB
- 0001178913-25-004131.txt ( ) — 19KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2025 (Report No. 2) Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F CONTENTS On December 30, 2025, the Company issued a press release titled "IM Cannabis Explores U.S. Market Entry Following President Trump's Executive Order on Increasing Medical Marijuana and Cannabidiol Research," a copy of which is furnished as Exhibit 99.1 with this Report of Foreign Private Issuer on Form 6-K (this "Report"). This Report is incorporated by reference into the Company's Registration Statements on Form F-3 (File No. 333-289571 and 333-288346 ) filed with the Securities and Exchange Commission to be a part thereof from the date on which this Report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished. EXHIBIT INDEX Exhibit No. 99.1 Press Release dated December 30, 2025 titled "IM Cannabis Explores U.S. Market Entry Following President Trump's Executive Order on Increasing Medical Marijuana and Cannabidiol Research". SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IM CANNABIS CORP. Date: December 30, 2025 By: /s/ Oren Shuster Name: Oren Shuster Title: Chief Executive Officer and Director